5-10
2026
影响因子区间
—
平台估算
18%
2025
中国作者发文占比
1969 USD
收费
期刊简介:The journal provides a unique forum for scientific publication of high-quality research that is exclusively focused on translational aspects of drug delivery. Rationally developed, effective delivery systems can potentially affect clinical outcome in different disease conditions.Research focused on the following areas of translational drug delivery research will be considered for publication in the journal.Designing and developing novel drug delivery systems, with a focus on their application to disease conditions;Preclinical and clinical data related to drug delivery systems;Drug distribution, pharmacokinetics, clearance, with drug delivery systems as compared to traditional dosing to demonstrate beneficial outcomesShort-term and long-term biocompatibility of drug delivery systems, host response;Biomaterials with growth factors for stem-cell differentiation in regenerative medicine and tissue engineering;Image-guided drug therapy,Nanomedicine;Devices for drug delivery and drug/device combination products.In addition to original full-length papers, communications, and reviews, the journal includes editorials, reports of future meetings, research highlights, and announcements pertaining to the activities of the Controlled Release Society.
【译文】该期刊提供了一个独特的平台,用于发表高质量研究论文,专注于药物递送方面的转化研究。合理开发的、有效的递送系统有可能影响不同疾病条件下的临床结果。该期刊将考虑以下转化药物递送研究领域的论文发表:设计和发展新型药物递送系统,重点关注其应用于疾病条件;与传统给药相比,药物递送系统的药代动力学、分布、清除,以展示有益的结果;药物递送系统的短期和长期生物相容性,宿主反应;再生医学和组织工程中用于干细胞分化的生物材料;影像引导的药物治疗,纳米医学;药物递送设备和药物/设备组合产品。除了原创的全文论文、通讯和评论外,该期刊还包括社论、未来会议报告、研究亮点和控制释放学会活动的公告。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 中科院分区 | 2区 | 暂无 |
| 影响因子区间 | 5-10 | 暂无 |